- Company site
- Business Sector: Technology
- Business Sub-Sector: Computer Software
- Company Type: Private company
- Job Function: C-Level/Owner
- @GenomeCompiler: Enabling the design and creation of useful living things!
- I’m Looking For:
- Business Partners
- Employees to Recruit
- Products to Market
Omri Amirav-Drory, Ph.D. is the founder & CEO of Genome Compiler Corp, a Synthetic Biology venture. Prior to starting his company, Dr. Amirav-Drory was a Fulbright postdoctoral research fellow at Stanford University School of Medicine & HHMI, performing Neuroscience research using Structural and Synthetic Biology methods. Dr. Amirav-Drory received his Ph.D in Biochemistry from Tel-Aviv University for Biochemical and Structural studies of membrane protein complexes involved in bio-energetics.
My main motivation in starting Genome Compiler was the realization that our civilization is totally dependent on finite resources of coal, oil and natural gas to produce almost everything we need. From energy, fuels, chemicals, foods, drugs, plastics, fertilizers, pesticides and much more. Synthetic biology has the potential to solve this huge problem by reprogramming living things that can scale to meet our global challenges.
There are three main obstacles in this new space: the price of DNA, lack of complete biological knowledge and CAD/CAM tools to empower the genetic engineers and democratize this field. With the reduction of price of both reading and writing DNA (sequencing, synthesis), and the increase in the size of construct one can build, the need arises for computer aided design tools for this field.